BCL2L10 and hepatocellular carcinoma: The expression of the gene encoding Bcl-2-like protein 10 (BCLB) could be reduced by DNA methylation, and the decreased BCLB expression might be a therapeutic target for HCC because the gene is involved in HCC development [23].